Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Actavis Inc       US9426831031

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on ACTAVIS INC
2013DJJANUS CAPITAL MANAGEMENT 3Q 13F : Largest Purchases
2013DJFARALLON CAPITAL MANAGEMENT 3Q 13F : Holdings As Of Sep 30
2013DJTWO SIGMA INVESTMENTS 3Q 13F : Largest Sales -2-
2013DJTWO SIGMA INVESTMENTS 3Q 13F : Largest Sales
2013DJETON PARK CAPITAL MANAGEMENT LP 3Q 1 : Holdings As Of Sep 30
2013DJCR INTRINSIC INVESTORS 3Q 13F : Largest Eliminations
2013 ACTAVIS PLC : Actavis Confirms Generic Axiron® Patent Challenge
2013DJGAMCO ASSET MANAGEMENT INC. 3Q 13F : Largest -2-
2013DJGAMCO ASSET MANAGEMENT INC. 3Q 13F : Largest Purchases
2013DJTHE VANGUARD GROUP 3Q 13F : Largest Sales
2013DJTHE VANGUARD GROUP 3Q 13F : Largest Sales -2-
2013 ACTAVIS PLC : Actavis Confirms Generic Absorica® Patent Challenge
2013 ACTAVIS PLC : Five Star Equities Issues New Research Reports on ACT, GT, HUN and..
2013DJU.S. HOT STOCKS FUTURES : Hot Stocks to Watch
2013 ACTAVIS PLC : Actavis Net Revenue Increases 57% to $2.01 Billion in Third Quarte..
2013 ACTAVIS PLC : Actavis Confirms Generic Acanya® Gel Patent Challenge
2013 WATSON PHARMACEUTICALS, INC. : is Now Actavis, Inc.
2013 WATSON PHARMACEUTICALS, INC. : Watson Confirms Opana® ER Patent Challenge
2013 WATSON PHARMACEUTICALS, INC. : Watson Acquires Uteron Pharma SA
2013 WATSON PHARMACEUTICALS, INC. : Watson To Host 2013 Investor Meeting January 25 I..
2013 WATSON PHARMACEUTICALS, INC. : Watson's Generic Lysteda® Receives FDA Approval
2012 WATSON PHARMACEUTICALS, INC. : Watson Launches Generic Biaxin(R) XL
2012 WATSON PHARMACEUTICALS, INC. : Watson Receives FDA Approval For Oxycodone And Ac..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Velcade® Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the 31st Annual J.P. Morgan ..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at 2013 Goldman Sachs Healthcar..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the 2012 Piper Jaffray Healt..
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Revatio® Receives FDA Approval
2012DJFDA Panel Splits on Merck Plan to Sell Bladder Drug Over-The-Counter
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the Jefferies 2012 Global He..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the 2012 Annual Credit Suiss..
2012 WATSON PHARMACEUTICALS, INC. : Watson Third Quarter 2012 Non-GAAP Diluted EPS In..
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces New Name -- Actavis -- for Globa..
2012 WATSON PHARMACEUTICALS, INC. : Watson Completes Actavis Acquisition
2012WATSON PHARMACEUTICALS, INC. : quaterly earnings release
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces Sale of Rugby OTC Product Tradem..
2012 WATSON PHARMACEUTICALS, INC. : Watson Receives FDA Approval for Generic Actos®
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms FDA Denies Appeal Related to Proc..
2012DJMylan CEO Eyes Acquisitions Valued at More than $4 Billion
2012DJMylan CEO Eyes Acquisitions Valued at More than $4 Billion
2012DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2012 WATSON PHARMACEUTICALS, INC. : Watson Receives Favorable Court Decision Regardin..
2012 WATSON PHARMACEUTICALS, INC. : Watson Sells Minority Shareholding Position in Mo..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Host Third Quarter 2012 Earnings Confer..
2012 WATSON PHARMACEUTICALS, INC. : Actavis forecasts 2012 sales in excess of 2 billi..
2012 WATSON PHARMACEUTICALS, INC. : Par to Acquire 14 Generic Products
2012DJWATSON PHARMACEUTICALS, INC. : FTC Clears Watson-Actavis Deal, With Conditions
2012 WATSON PHARMACEUTICALS, INC. : Watson Receives FTC Clearance for Actavis Acquisi..
2012DJWatson Pharmaceuticals Gains FDA Approval for Two Generics
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Sanctura XR® Receives FDA Appro..
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Avapro® Receives FDA Approval
2012 WATSON PHARMACEUTICALS, INC. : Watson Receives Approval from European Commission..
2012DJFDA Withdrawing Approval of 1 Impax/Teva Generic Wellbutrin Product
2012 U.S. finds no wrongdoing in Yasmin patent settlement
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Favorable District Court Ruling i..
2012 WATSON PHARMACEUTICALS, INC. : Watson Prices $3.9 Billion of Senior Unsecured No..
2012DJJumbo Deals Push Monthly Corporate Bond Volume to $115 Billion
2012 WATSON PHARMACEUTICALS, INC. : Watson Announces Offering of Senior Unsecured Not..
2012 WATSON PHARMACEUTICALS, INC. : Watson Issues Voluntary Nationwide Recall of Hydr..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the 2012 Bank of America Mer..
2012 WATSON PHARMACEUTICALS, INC. : Watson to Present at the Morgan Stanley 2012 Glob..
2012DJU.S. HOT STOCK FUTURES : Hot stocks to watch
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Lidoderm(R) Receives FDA Approva..
2012 WATSON PHARMACEUTICALS, INC. : Watson Launches Generic Xopenex®
2012DJWatson Pharma Sues FDA
2012 WATSON PHARMACEUTICALS, INC. : Watson Sues FDA Regarding Delay of Generic Actos®..
2012 WATSON PHARMACEUTICALS, INC. : Watson Applauds GPhA Study Demonstrating $1 Trill..
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Version of Pulmicort RESPULES® R..
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Xopenox HFA® Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson Confirms Epiduo® Gel Patent Challenge
2012 WATSON PHARMACEUTICALS, INC. : Watson Second Quarter 2012 Non-GAAP Diluted EPS I..
2012DJWATSON PHARMACEUTICALS : FDA Approves Generic of Teva's Plan B Emergency Contrac..
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic Version of Plan B One-Step® Rece..
2012 WATSON PHARMACEUTICALS, INC. : Watson and Actavis Receive FTC Second Request
2012 WATSON PHARMACEUTICALS, INC. : Watson's Generic ARTHROTEC(R) Receives FDA Approv..
Prev.1   2  3  4  5  6  7Next
Advertisement
Dynamic quotes  
ON
| OFF